Journal article
FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1)
SJ Feeney, MJ McGrath, A Sriratana, SM Gehrig, GS Lynch, CED Arcy, JT Price, CA McLean, R Tupler, CA Mitchell
Plos One | PUBLIC LIBRARY SCIENCE | Published : 2015
Abstract
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal-dominant disease with no effective treatment. The genetic cause of FSHD is complex and the primary pathogenic insult underlying the muscle disease is unknown. Several disease candidate genes have been proposed including DUX4 and FRG1. Expression analysis studies of FSHD report the deregulation of genes which mediate myoblast differentiation and fusion. Transgenic mice overexpressing FRG1 recapitulate the FSHD muscular dystrophy phenotype. Our current study selectively examines how increased expression of FRG1 may contribute to myoblast differentiation defects. We generated stable C2C12 cell lines overexpressing FRG1, which exhibit..
View full abstractGrants
Awarded by National Institute of Arthritis and Musculoskeletal and Skin Diseases
Funding Acknowledgements
This work was supported by the FSHD Global Research Foundation Ltd Australian Research Grants (to C.A.M. and M.J.M.; http://www.fshdglobal.org/); and the National Institute of Health (NIAMS, RO1AR056129 to R.T; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.